Style | Citing Format |
---|---|
MLA | Enayatollahi M, et al.. "What Are the Contraindications, If Any, for the Use of Tranexamic Acid During Knee or Hip Arthroplasty?." Journal of Arthroplasty, vol. 40, no. 2, 2025, pp. S21-S24. |
APA | Enayatollahi M, Azboy I, Dietz MJ, Aunon A, Heshmat R, Dragosloveanu S, Ehsani A, Scheau C, Shafiee G, Ghamgosar A, Cetin H, Demir B, Palmer A (2025). What Are the Contraindications, If Any, for the Use of Tranexamic Acid During Knee or Hip Arthroplasty?. Journal of Arthroplasty, 40(2), S21-S24. |
Chicago | Enayatollahi M, Azboy I, Dietz MJ, Aunon A, Heshmat R, Dragosloveanu S, Ehsani A, et al.. "What Are the Contraindications, If Any, for the Use of Tranexamic Acid During Knee or Hip Arthroplasty?." Journal of Arthroplasty 40, no. 2 (2025): S21-S24. |
Harvard | Enayatollahi M et al. (2025) 'What Are the Contraindications, If Any, for the Use of Tranexamic Acid During Knee or Hip Arthroplasty?', Journal of Arthroplasty, 40(2), pp. S21-S24. |
Vancouver | Enayatollahi M, Azboy I, Dietz MJ, Aunon A, Heshmat R, Dragosloveanu S, et al.. What Are the Contraindications, If Any, for the Use of Tranexamic Acid During Knee or Hip Arthroplasty?. Journal of Arthroplasty. 2025;40(2):S21-S24. |
BibTex | @article{ author = {Enayatollahi M and Azboy I and Dietz MJ and Aunon A and Heshmat R and Dragosloveanu S and Ehsani A and Scheau C and Shafiee G and Ghamgosar A and Cetin H and Demir B and Palmer A}, title = {What Are the Contraindications, If Any, for the Use of Tranexamic Acid During Knee or Hip Arthroplasty?}, journal = {Journal of Arthroplasty}, volume = {40}, number = {2}, pages = {S21-S24}, year = {2025} } |
RIS | TY - JOUR AU - Enayatollahi M AU - Azboy I AU - Dietz MJ AU - Aunon A AU - Heshmat R AU - Dragosloveanu S AU - Ehsani A AU - Scheau C AU - Shafiee G AU - Ghamgosar A AU - Cetin H AU - Demir B AU - Palmer A TI - What Are the Contraindications, If Any, for the Use of Tranexamic Acid During Knee or Hip Arthroplasty? JO - Journal of Arthroplasty VL - 40 IS - 2 SP - S21 EP - S24 PY - 2025 ER - |